165 - Interim Analysis of Investigator-Initiated Phase 2 Trial of Siltuximab in Treatment of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Related to CAR T-Cell Therapy

Autor: Narkhede, Mayur, Stasi, Antonio Di, Bal, Susan, Shea, Lauren K, Goyal, Gaurav, Sledge, Alexandria, Hardwick, Pamela, Giri, Smith, Mehta, Amitkumar

Publikováno v: In Transplantation and Cellular Therapy February 2023 29(2) Supplement:S133-S134

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation

Autor: Poon, Limei Michelle, Stasi, Antonio Di, Popat, Uday, Champlin, Richard E, Ciurea, Stefan O

Delayed recovery of platelet count post allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been associated with worse transplant outcomes. Thrombopoietic agents have been successfully used in immune mediated thrombocytopenia or thromb

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::afc9266a8b396ce660d523a994fbaf11
https://europepmc.org/articles/PMC3755526/

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

Autor: Stasi, Antonio Di ^*, Poon, LM ^*, Ferro, Roberto ^*, Milton, Denai ^*, Rondon, Gabriela ^*, Wang, Sa A. ^*, Hamdi, Amir ^*, Qazilbash, Muzaffar H., Ahmed, Sairah, Khouri, Issa, Oran, Betul ^*, Hosing, Chitra M., Kebriaei, Partow, Alousi, Amin, Popat, Uday R, Shpall, Elizabeth J, Lee, Dean A., Rezvani, Katy ^*, Champlin, Richard E, Ciurea, Stefan O.

Publikováno v: In Blood 15 November 2013 122(21):2167-2167

Clinical-scale manufacturing of γδ T cells for protection against infection and disease recurrence following haploidentical peripheral blood stem cell transplantation and cyclophosphamide gvhd prophylaxis.

Autor: Lamb LS; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. lslamb@uabmc.edu., Pillai S; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Langford S; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Bowersock J; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Stasi AD; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Saad A; Department of Medicine, Blood and Marrow Transplantation and Cell Therapy Program, Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2018 Jun; Vol. 53 (6), pp. 766-769. Date of Electronic Publication: 2018 Mar 07.